Create Free Account

By creating account you will get access to hot stocks & personalised emails

Mayne Pharma Group Ltd

Healthcare AU MYX

4.89AUD
-0.41(7.74%)

Last update at 2024-11-13T05:10:00Z

Day Range

4.845.30
LowHigh

52 Week Range

3.747.46
LowHigh

Fundamentals

  • Previous Close 5.30
  • Market Cap376.88M
  • Volume199570
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA18.80M
  • Revenue TTM388.40M
  • Revenue Per Share TTM4.88
  • Gross Profit TTM 83.49M
  • Diluted EPS TTM-2.12

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -269.69800M -217.81800M -263.88700M -135.36700M -353.71700M
Minority interest 0.09M 10.61M 3.22M 4.77M 6.31M
Net income 117.25M -263.34300M -208.42300M -92.78900M -283.75100M
Selling general administrative 37.21M -28.65100M 29.52M 61.83M 81.95M
Selling and marketing expenses 125.94M 104.60M 56.82M 74.20M 76.67M
Gross profit 85.43M 170.15M 194.74M 225.11M 301.36M
Reconciled depreciation 65.44M 81.08M 68.19M 77.07M 94.50M
Ebit -162.99700M 11.32M 7.28M 3.50M 15.44M
Ebitda -97.55600M 92.40M 75.47M 88.06M 109.94M
Depreciation and amortization 65.44M 81.08M 68.19M 84.56M 94.50M
Non operating income net other - - - - -
Operating income -183.43400M -122.52700M -12.40400M -13.13100M 15.44M
Other operating expenses -249.38200M -121.34400M -215.73300M -86.30000M 501.51M
Interest expense 28.39M 32.10M 32.35M 31.54M 17.44M
Tax provision 50.43M 56.13M -54.80500M -39.14500M -74.84300M
Interest income 6.72M 0.46M 0.69M 0.79M 1.02M
Net interest income -22.13100M -31.96800M -32.13300M -31.54200M -16.42800M
Extraordinary items 437.28M -0.49200M -0.35700M 1.69M -3.21400M
Non recurring - - - - -
Other items - - - - -
Income tax expense 47.74M 56.13M -54.80500M -40.83200M -69.96600M
Total revenue 185.53M 423.92M 400.32M 456.60M 523.96M
Total operating expenses 252.12M 171.69M 173.44M 245.34M 278.92M
Cost of revenue 100.10M 253.77M 205.58M 231.49M 222.60M
Total other income expense net -89.66500M -204.20300M -253.05600M -91.88000M -369.16000M
Discontinued operations 434.60M -71.80500M -71.80500M -71.80500M -
Net income from continuing ops -317.44300M -273.95000M -209.08200M -94.53500M -283.75100M
Net income applicable to common shares 117.25M -263.34300M -208.42300M -92.78900M -279.20300M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 1143.23M 1247.35M 1287.93M 1463.18M 1825.18M
Intangible assets - 617.26M 405.39M 615.81M 940.12M
Earning assets - - - - -
Other current assets 26.69M 28.17M 37.80M 32.76M 63.26M
Total liab 689.04M 612.99M 730.81M 691.61M 782.87M
Total stockholder equity 454.19M 634.36M 564.77M 768.36M 1037.55M
Deferred long term liab - 2.04M -729.16300M -491.28300M 40.70M
Other current liab 282.71M 22.85M 138.86M 126.12M 144.57M
Common stock 1224.22M 1233.69M 1238.54M 1238.54M 1238.58M
Capital stock - 1233.69M 1238.54M 1238.54M 1238.58M
Retained earnings -944.00300M -769.77000M -822.40600M -559.06300M -350.64000M
Other liab - 268.96M 114.71M 176.30M 210.40M
Good will - 0.00000M 22.13M 20.35M 22.17M
Other assets 0.00000M 24.98M -606.22400M -302.37600M 174.40M
Cash 112.39M 92.62M 96.67M 97.98M 137.78M
Cash and equivalents - - - - -
Total current liabilities 313.94M 310.96M 610.42M 222.53M 219.25M
Current deferred revenue 6.54M 241.65M 121.14M 90.04M 95.28M
Net debt -73.56800M -45.11100M 316.99M 248.84M 260.26M
Short term debt 3.82M 14.43M 407.99M 54.04M 44.84M
Short long term debt - 10.81M 405.37M 51.16M 44.84M